Mentor Capital Inc (MNTR) 0.4000 $MNTR Penny Stocks To

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mentor Capital Inc (MNTR) 0.4000 $MNTR

Penny Stocks To Buy: Four Trending Small Cap Stocks on Tuesday April 19
ACCESSWIRE - Tue Apr 19, 9:51AM CDT
MIAMI, FL / ACCESSWIRE / April 19, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. AVRN, MNTR, CHZP, and AGHI have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the OTC, Nasdaq and NYSE subscribe to our newsletter at DailyStockReporter.com.

Mentor Capital Acquires International Vaporizer THC & CBD Patent
BusinessWire - Fri Apr 08, 6:47AM CDT
Mentor Capital, Inc. (OTCQB:MNTR) announced that it has acquired the international patent for the smokeless administration of THC, CBD and Cannabinoids, from its developer R.L. Larson through Larson Capital, LLC.

Mentor Capital 2015 Revenues Gain 19% to $2.6 Million in 10-K
BusinessWire - Mon Mar 28, 6:47AM CDT
Mentor Capital, Inc. (OTCQB: MNTR) announced that it has filed its annual 10-K filing for the year ended December 31, 2015 with the SEC.

Mentor Capital Cannabis Index Gains During Election Cycle
BusinessWire - Mon Mar 21, 6:47AM CDT
Mentor Capital, Inc. (OTCQB:MNTR) announced that Mentor's Cannabis Index for Value Investors has gained 22% YTD during 2016. According to Mentor CEO, Chet Billingsley, "The index was boosted by GW Pharmaceuticals' (NASDAQ:GWPH) recent doubling after its cannabidiol drug for childhood epilepsy received a positive nod from the FDA." The other leaders reported by Mentor in its marijuana index were indoor cultivation system experts Surna, Inc., (OTCQB:SRNA) at (326%) and new cannabis patent participant Mentor Capital at (354%), when compared to NASDAQ average unit sales, book value and growth set together at (100%).
GWPH: 94.83 (+1.36)

Mentor Capital Awarded $750,000 Judgment
BusinessWire - Tue Mar 08, 11:14AM CST
Mentor Capital, Inc. (OTCQB:MNTR) announces that it has received a $746,500.29 judgment against Wm. E. Fielding and Associates, Inc. of Delray Beach, Florida, as U.S. receiving and forwarding agent for Global Guarantee Corporation, S.A. of Dublin, Ireland. The award was for Fielding's role in failing to return $621,250 in refundable loan insurance premiums after an international loan did not fund, plus interest and costs.

Mentor Capital Releases 2016 Cannabis Value Index
BusinessWire - Wed Jan 20, 6:30AM CST
Mentor Capital, Inc. (OTCQB:MNTR) announces that Mentor's 2016 Cannabis Index for Value Investors is led by Digipath, Inc. (OTCQBIGP) at (621%); Mentor Capital at (460%), and Cannavest Corp. (OTCQB:CANV) at (333%) when compared to NASDAQ average unit sales, book value and growth set together at (100%).
GWPH: 94.83 (+1.36)

Mentor Capital Has Five Best Congressional Cannabis Resolutions for 2016
BusinessWire - Thu Dec 31, 12:53PM CST
Mentor Capital, Inc. (OTCQB: MNTR) CEO Chet Billingsley sat down with California congressional candidate Marcus Musante to relay Mentor's Five Best Cannabis Resolutions for the U.S. Congress for 2016:

Mentor Capital Releases Cannabis Index for Value Investors
BusinessWire - Fri Dec 11, 10:20AM CST
Mentor Capital, Inc. (OTCQB:MNTR) announces that the leaders in Mentor's new Cannabis Index for Value Investors were Mentor Capital at (252%), Terra Tech (OTCQX:TRTC) at (86%) and GW Pharmaceuticals Plc. (NASDAQ: GWPH) at (33%) when compared to the NASDAQ average set at (100%). Sales plus book value were compared to market capitalization for leading marijuana stocks to establish this new marijuana stock index.
GWPH: 94.83 (+1.36)

Mentor Capital Again Leads in Marijuana Investment Sector
BusinessWire - Wed Dec 02, 9:01AM CST
Mentor Capital, Inc. (OTCQB: MNTR) is pleased to announce that Viridian Capital Advisors has again this year ranked Mentor Capital first in its just released and comprehensive Viridian Cannabis Stock Index Report for early 2015. In their report, Viridian noted that in the Investments/M&A sector, "While most of the stocks in this sector fell, Mentor Capital (OTCQB:MNTR) realized double-digit gains, up 20.0% following a rally in early January."

Mentor Capital Files 10-Q with Growing 12 Month Trailing Revenue of $2.5 Million
BusinessWire - Tue Nov 17, 9:59AM CST
Mentor Capital, Inc. (OTCQB: MNTR) announced that it has filed its quarterly 10-Q filing for the third quarter ending September 30, 2015 with the SEC.

Mentor Capital Reports on Cannabis 3.0 in Las Vegas
BusinessWire - Mon Nov 16, 1:43PM CST
Mentor Capital, Inc. (OTCQB: MNTR) observes that the face of marijuana is changing. In 2013 and in 2015 last week, Mentor went to the largest marijuana trade show in the USA to meet with the CEOs of marijuana companies. In 2013 the forum was the club house of a horse racing track with around 750 attendees. Following a few notable pioneers, a handful of people with experience in the marijuana business and a love for the plant, were exchanging tie dye for casual to make a legitimate name for themselves. $800,000 in annual revenue made one a for-profit market leader. Mentor was one of two financial professionals in attendance.

Mentor Capital Now a Delaware Company
BusinessWire - Tue Oct 27, 9:53AM CDT
Mentor Capital, Inc. (OTCQB: MNTR) announced that its legal move to Delaware is complete. "Our goal was to establish the legal base for completing securities compliant spinoffs of quality cannabis and medical marijuana companies in a cost effective manner," explains Mentor CEO, Chet Billingsley. "Delaware has a well codified securities and business law system that well supports Mentor's comprehensive program and is often the choice of domicile for more sophisticated NASDAQ and NYSE companies."

Mentor Capital Files 10-Q with 23% Revenue Growth for 2nd Qtr
BusinessWire - Fri Aug 14, 8:35AM CDT
Mentor Capital, Inc. (OTCQB: MNTR) announced that it has filed its quarterly 10-Q filing for the second quarter ending June 30, 2015 with the SEC.

Mentor Capital Anchors Women Grow Event on Cannabis Funding
BusinessWire - Fri Jun 05, 10:15AM CDT
Mentor Capital, Inc. (OTCQB: MNTR) reports that CEO, Chet Billingsley, presented and explained the range of financing options available over the life cycle of a cannabis business. The packed audience was gathered at the Women Grow event in Orange County and included Mentor shareholders, marijuana entrepreneurs and potential candidates to be taken public by Mentor Capital via spinoff to its shareholders. Family and friends financing, grants, SBA loans, private placements, the emotions of asking for funds, reverse mergers and founder's risks on Wall Street were all personally familiar topics discussed by CEO Billingsley who founded Mentor with $1,000 and grew that small savings into the leading M&A and Investment public company in the cannabis sector.

Mentor Capital on Cannabis Investor Webcast June 4th at 11:00 am EDT
BusinessWire - Wed Jun 03, 8:54AM CDT
Mentor Capital, Inc. (OTCQB: MNTR) announced it is invited and will present live for 45 minutes on the Cannabis Investor Webcast on Thursday, June 4, 2015, at 11:00 am Eastern time, 8:00 am Pacific. Mentor Capital CEO Chet Billingsley will discuss Mentor's emerging program to act as a public market incubator to assist solid cannabis and medical marijuana companies to go public via spinoff. The webcast will also include a cannabis sector overview by Michael Berger of Technical420 with other presentations and Q & A sessions from different private and public cannabis related companies.

Mentor Capital CEO on MoneyShow Cannabis Expert Panels
BusinessWire - Mon May 11, 6:55AM CDT
Mentor Capital, Inc. (OTCQB: MNTR) reports that its CEO, Chet Billingsley, will be a guest speaker at two cannabis investment panels this Monday and Tuesday at the MoneyShow being held at Caesar's Palace in Las Vegas. The May 11th panel is titled "Meet the Experts Behind Medical Marijuana: Your Top Investments in this Growing Industry for 2015" and is hosted by Matt McCall, founder of the Penn Financial Group. The Tuesday panel is hosted by Scott Greiper, the founder of Viridian Capital, and covers "Investing in the Next Big High Growth Sector" and will be webcast at 4:45 PM.

Mentor Capital Acquires Cannabis Investor Webcast on 4.20
BusinessWire - Wed Apr 22, 7:48AM CDT
Mentor Capital, Inc. (OTCQB: MNTR) reports that it has acquired 100% of Cannabis Investor Webcast as the first member of Mentor Capital's Public Market Incubator Program. "We are extremely pleased to be backing and mentoring founder Derwin A. Wallace who has the creativity, high energy and investor knowledge required to grow and enter his high margin business into the public company ranks," says Mentor CEO, Chet Billingsley. "While his business is groomed for public status, he and his original investors may enjoy public market liquidity by being able to sell the Mentor Capital, Inc. acquisition shares received, after a holding period." The Mentor program allows founders to roll unsold or still retained acquisition shares into any later IPO. At that time, a significant block of the remaining Cannabis Investor Webcast shares may be sent by special dividend into the hands of Mentor Capital's 4,000 shareholders. This essentially creates a second spinoff public company for them, at cost, with a robust cannabis interested trading base. According to Mentor, the spinoff approach avoids the large expense and especially the 10% to 15% ownership slice extracted from owners and then often dumped in the market when a reverse merger is used by private cannabis companies to become public.

Mentor Capital Arranges $1.3 Million in Long Term Cannabis Financing at $1.70 per Share
BusinessWire - Tue Apr 14, 6:47AM CDT
Mentor Capital, Inc. (OTCQB: MNTR) reports that it has entered into a contract to receive $1,287,000 in funding to support its medical marijuana efforts in exchange for 757,059 shares at a price of $1.70 per share. The long-term funding will be delivered evenly over an eleven year schedule which implies a 17.73% annual growth rate for Mentor Capital, Inc. According to the Company, the investing party will become a 4.9% shareholder in exchange for cash infusions over time equal to approximately 11.5% of the current market capitalization of Mentor Capital.

Mentor Capital Adds Stansfield to Board Supporting Spinoffs
BusinessWire - Fri Apr 10, 11:17AM CDT
Mentor Capital, Inc. (OTCQB: MNTR) announced it has appointed Ms. Lori Stansfield, CPA to its Board of Directors effective immediately. Ms. Stansfield will now also add the corporate officer title of Treasurer to her operating role as company CFO. "In addition to comprehensive CFO responsibilities, one strategic function of Mentor Capital that Ms. Stansfield will focus on is to ready future portfolio companies to be spun off as standalone public companies," says Mentor Capital CEO, Chet Billingsley. "Central to Mentor's public incubator role is ensuring cannabis companies we work with have pristine GAAP and SEC compliant financial statements that they will need to become public themselves. As a former Director of Audit Services, Ms. Stansfield is eminently qualified to oversee this process and her authority is strengthened as a director and corporate officer."

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 25

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 231

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 48

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover How Indovinya's Innovations Boost Sustainable Agriculture

Updated Category News Views 93

Unlocking the Potential of Biopesticides in Agriculture Indovinya introduces innovative solutions to enhance the use of biologically based products amidst a growing drive for sustainable crop protection. Advancements in Biopesticide Utilization The adoption of biopesticides as an alternative to traditional agrochemicals is gaining traction. However, the integration of...

Continue Reading
SCHMID Group Expands Influence with New Equipment Orders

Updated Category News Views 155

SCHMID Group Strengthens Market Position with New Orders In an exciting development from the SCHMID Group, a key player in the equipment manufacturing sector, the company has recently secured significant orders for Panel Level Packaging (PLP) and modified Semi-Additive (mSAP) production equipment. The orders mark a noteworthy advance as SCHMID continues to bolster its...

Continue Reading
X4 Pharmaceuticals Completes Major Equity Financing and Leadership Shift

Updated Category News Views 178

Major Equity Financing by X4 Pharmaceuticals X4 Pharmaceuticals has made headlines recently with its announcement of a significant private equity financing round totaling $60 million. This funding is primarily geared towards advancing the company’s promising treatment for rare immune system diseases, demonstrating their commitment to improving patient outcomes. Leading...

Continue Reading
IGI Secures Fast Track from FDA for Promising Cancer Treatment

Updated Category News Views 124

IGI Receives Fast Track Designation for ISB 2001 Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001, an innovative treatment for heavily pretreated multiple myeloma patients, will be showcased at an upcoming major oncology conference. This exciting news highlights IGI's continued progress in developing groundbreaking therapies. About ISB...

Continue Reading
Prospera Energy Reports Strong Financial Performance for 2024

Updated Category News Views 163

Prospera Energy's Transformative Year: A Deep Dive into 2024 Financial Results In the recent strategic realignment, Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) has successfully pivoted under new leadership, making significant strides in enhancing its production capabilities and financial outlook. This transformation was marked by key appointments, including Shubham Garg...

Continue Reading